STAA · Nasdaq · CIK 0000718937

STAAR SURGICAL CO

STAAR SURGICAL CO’s most recent SEC filing in our snapshot is a Form SCHEDULE 13G/A filed on Oct 27, 2026. In fiscal 2026 (year ended Jan 2, 2026) it reported revenue of $239.4M and net income of -$80.4M, according to its XBRL data on EDGAR. Its EDGAR record lists 33 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2026
$239.4M
Net income, FY2026
-$80.4M
Form 4 filings on record, past 12 months
33

Company overview

Legal name (as filed)
STAAR SURGICAL CO
Ticker
STAA
SEC Central Index Key (CIK)
0000718937
Industry (SIC)
Ophthalmic Goods (code 3851)
Business address
MONROVIA, CA
State or country of incorporation
DE
Fiscal year ends
January 2
SEC filer category
Large accelerated filer
Position in SEC ticker list
#2351 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from STAAR SURGICAL CO’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$230.5MFY2021$239.4MFY2022$322.4MFY2023$313.9MFY2024$239.4MFY2026
Net income
$27.5MFY2021$39.7MFY2022$21.3MFY2023-$20.2MFY2024-$80.4MFY2026
STAA annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 30, 2022		FY2023
ended Dec 29, 2023		FY2024
ended Dec 27, 2024		FY2026
ended Jan 2, 2026
Revenue$230.5M$239.4M$322.4M$313.9M$239.4M
Net income$27.5M$39.7M$21.3M-$20.2M-$80.4M
Diluted EPS$0.56$0.80$0.43-$0.41-$1.62
Total assets$345.8M$418.8M$488.7M$509.5M$451.7M
Cash and equivalents$199.7M$86.5M$183.0M$144.2M$153.2M

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

STAA latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 3, 202610-KAnnual report· period Jan 2, 2026Document · Index
Aug 12, 202610-QQuarterly report· period Jul 3, 2026Document · Index
Sep 10, 20268-KDirector or officer change; Regulation FD disclosure· period Sep 9, 2026Document · Index
May 4, 2026DEF 14ADefinitive proxy statement· period May 1, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about STAAR SURGICAL CO, by form type:

4 ×208-K ×7SCHEDULE 13G/A ×410-Q ×2SCHEDULE 13G ×28-K/A ×1S-8 ×1ARS ×1DEFA14A ×1DEF 14A ×1
STAA recent filings
FiledFormWhat it isOriginal
Oct 27, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Oct 5, 20268-K/ADirector or officer change; Regulation FD disclosure· period Sep 8, 2026Document · Index
Sep 10, 20268-KDirector or officer change; Regulation FD disclosure· period Sep 9, 2026Document · Index
Aug 18, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Aug 18, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Aug 18, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Aug 14, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 12, 202610-QQuarterly report· period Jul 3, 2026Document · Index
Aug 12, 20268-KResults of operations; Regulation FD disclosure· period Aug 12, 2026Document · Index
Aug 6, 20268-KDirector or officer change; Regulation FD disclosure· period Aug 5, 2026Document · Index
Aug 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 31, 2026Document · Index
Aug 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 25, 2026Document · Index
Jun 24, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Jun 23, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026Document · Index
Jun 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026Document · Index
Jun 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026Document · Index
Jun 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026Document · Index
Jun 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026Document · Index
Jun 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026Document · Index
Jun 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026Document · Index
Jun 22, 20268-KDirector or officer change; Shareholder vote results· period Jun 18, 2026Document · Index
Jun 15, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 12, 2026Document · Index
Jun 9, 20268-KDirector or officer change· period Jun 9, 2026Document · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 15, 2026Document · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 15, 2026Document · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 15, 2026Document · Index
May 13, 202610-QQuarterly report· period Apr 3, 2026Document · Index
May 13, 20268-KResults of operations; Regulation FD disclosure· period May 12, 2026Document · Index
May 12, 20264Statement of changes in beneficial ownership (insider trade)· period May 8, 2026Document · Index
May 12, 20264Statement of changes in beneficial ownership (insider trade)· period May 8, 2026Document · Index
May 12, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
May 4, 2026ARSARS· period Jan 2, 2026Document · Index
May 4, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
May 4, 2026DEF 14ADefinitive proxy statement· period May 1, 2026Document · Index
Apr 24, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Apr 20, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Apr 8, 20268-KRegulation FD disclosure· period Apr 8, 2026Document · Index
Mar 27, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Mar 16, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 12, 2026Document · Index
Mar 16, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 12, 2026Document · Index

Insider filing activity

33 Form 4 filings appear in STAAR SURGICAL CO’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Ophthalmic Goods

All 6 companies in Ophthalmic Goods· Companies headquartered in California

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000718937 and XBRL company facts. STAAR SURGICAL CO on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.